Found: 26
Select item for more details and to access through your institution.
Communicating the new pharmacovigilance landscape.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
The Authors' Reply.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Olanzapine in schizophrenia and affective disorders.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Balancing the risks and benefits of the use of over-the-counter pain medications in children.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Neuropsychiatric adverse events and oseltamivir for prophylaxis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project).
- Published in:
- 2012
- By:
- Publication type:
- journal article
Acknowledgement.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1081, doi. 10.2165/11641760-000000000-00000
- Publication type:
- Article
First Workshop on Computational Methods in Pharmacovigilance held during the Medical Informatics in Europe (MIE) Conference, Pisa, Italy, 29 August 2012.
- Published in:
- 2012
- Publication type:
- Abstract
Global Patterns of Adverse Drug Reactions Over a Decade Analyses of Spontaneous Reports to VigiBase™.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1171, doi. 10.2165/11631940-000000000-00000
- By:
- Publication type:
- Article
Reasons for and time to discontinuation of rimonabant therapy: a modified prescription-event monitoring study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
The Authors' Reply.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Olanzapine in Schizophrenia and Affective Disorders.
- Published in:
- 2012
- By:
- Publication type:
- Letter
The Authors' Reply.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Reasons for and Time to Discontinuation of Rimonabant Therapy A Modified Prescription-Event Monitoring Study.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1147, doi. 10.2165/11631330-000000000-00000
- By:
- Publication type:
- Article
Internet Accounts of Serious Adverse Drug Reactions A Study of Experiences of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1159, doi. 10.2165/11631950-000000000-00000
- By:
- Publication type:
- Article
Individual NSAIDs and Upper Gastrointestinal Complications A Systematic Review and Meta-Analysis of Observational Studies (the SOS Project).
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1127, doi. 10.2165/11633470-000000000-00000
- By:
- Publication type:
- Article
Balancing the Risks and Benefits of the Use of Over-the-Counter Pain Medications in Children.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1119
- By:
- Publication type:
- Article
Current Challenges and Controversies in Drug-Induced Liver Injury.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1099, doi. 10.2165/11632970-000000000-00000
- By:
- Publication type:
- Article
Suspected Herbal Hepatotoxicity Requirements for Appropriate Causality Assessment by the US Pharmacopeia.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1091, doi. 10.2165/11631960-000000000-00000
- By:
- Publication type:
- Article
Communicating the New Pharmacovigilance Landscape.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
How to Improve Communication for the Safe Use of Medicines? Discussions on Social Marketing and Patient-Tailored Approaches at the Annual Meetings of the WHO Programme for International Drug Monitoring.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1073, doi. 10.2165/11640530-000000000-00000
- By:
- Publication type:
- Article